Search results
KDIGO guidelines cover various topics related to kidney diseases, such as acute kidney injury, anemia, diabetes, and transplantation. They are based on evidence, expert consensus, and clinical practice.
- AKI
KDIGO is in the process of developing the Clinical Practice...
- GD
KDIGO is updating The 2021 Clinical Practice Guideline for...
- Hepatitis C in CKD
The 2022 Clinical Practice Guideline for the Prevention,...
- CKD Evaluation and Management
A wide range of key topics are addressed, including optimal...
- Living Kidney Donor
The 2017 Kidney Disease: Improving Global Outcomes (KDIGO)...
- Diabetes in CKD
The KDIGO 2022 Clinical Practice Guideline for Diabetes...
- Anemia in CKD
The target audience includes healthcare providers involved...
- Blood Pressure in CKD
The KDIGO 2021 Clinical Practice Guideline on the Management...
- AKI
The KDIGO 2024 CKD Guideline provides evidence-based recommendations for healthcare professionals, people with CKD and their caregivers, and policymakers. It covers topics such as CKD evaluation, risk assessment, complications, medication management, and patient-centered care.
The KDIGO 2024 guideline updates the 2012 guideline and provides evidence-based recommendations for the evaluation and management of chronic kidney disease (CKD). It covers CKD across the lifespan, risk assessment, progression, complications, medication, and care models, and is based on systematic reviews and GRADE approach.
31 paź 2023 · This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier.
25 sie 2021 · This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of complications and cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with CKD.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105 (4S):S117-S314. doi: 10.1016/j.kint.2023.10.018. Author. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Collaborators. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group:
25 maj 2021 · The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline on the topic. The aim is to assist clinicians caring for individuals with glomerular disease, both adults and children.
